Drug search by name
Dabrafenib Mesylate and Moxetumomab pasudotox
Determining the interaction of Dabrafenib Mesylate and Moxetumomab pasudotox and the possibility of their joint administration.
Check result:
Dabrafenib Mesylate <> Moxetumomab pasudotox
Relevance: 12.04.2023
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Dabrafenib Mesylate
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Moxetumomab pasudotox
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Dabrafenib Mesylate-Moxetumomab Pasudotox-tdfk
- Dabrafenib Mesylate-Moxetumomab pasudotox-tdfk Intravenous
- Dabrafenib Mesylate-Moxifloxacin
- Dabrafenib Mesylate-Moxifloxacin (Systemic)
- Dabrafenib Mesylate-Moxifloxacin Hydrochloride
- Dabrafenib Mesylate-Moxifloxacin Injection
- Moxetumomab pasudotox-Dacarbazine
- Moxetumomab pasudotox-Dacarbazine Intravenous, Injection
- Moxetumomab pasudotox-Daclatasvir
- Moxetumomab pasudotox-Daclatasvir Dihydrochloride
- Moxetumomab pasudotox-Daclizumab
- Moxetumomab pasudotox-Daclizumab Subcutaneous
Doktika World
Interaction with food and lifestyle
Disease interaction